PET Versus PET/CT Dual-Modality Imaging in Evaluation of Lung Cancer

Radiologic Clinics of North America

Volumn 45, Issue 4, 2007, Pages 639-644

  Freudenberg, Lutz S ^a   Rosenbaum, Sandra J ^a   Beyer, Thomas ^a   Bockisch, Andreas ^a   Antoch, Gerald ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18;

BREATHING; CANCER PATIENT; CANCER STAGING; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HUMAN; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW;

CARCINOMA, NON-SMALL-CELL LUNG; CONTRAST MEDIA; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM STAGING; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34547805665     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rcl.2007.05.003     Document Type: Review

References (41)

1. Jemal A., Thomas A., Murray T., et al. Cancer statistics, 2002. CA Cancer J Clin 52 (2002) 23-47
2. Brundage M.D., Davies D., and Mackillop W.J. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 122 (2002) 1037-1057
3. Greene F.L., Page D.L., Fleming I.D., et al. AJCC cancer staging manual. 6th edition (2002), Springer, New York
4. Smythe W.R. Treatment of stage I and II non-small cell lung cancer. Cancer Control 8 (2001) 318-325
5. Haura E.B. Treatment of advanced nonsmall cell lung cancer: a review of current randomised clinical trials and an examination of emerging therapies. Cancer Control 8 (2001) 326-336
6. Weber W.A., Dietlein M., Hellwig D., et al. PET with (18)F-fluorodeoxyglucose for staging of non-small cell lung cancer. Nuklearmedizin 42 (2003) 135-144
7. Glazer G.M., Gross B.H., Quint L.E., et al. Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. AJR Am J Roentgenol 144 (1985) 261-265
8. Lowe V.J., DeLong D.M., Hoffman J.M., et al. Optimum scanning protocol for FDGPET evaluation of pulmonary malignancy. J Nucl Med 36 (1995) 883-887
9. Deslauriers J., and Gregoire J. Clinical and surgical staging of non-small cell lung cancer. Chest 117 (2000) 96S-103S
10. Staples C.A., Muller N.L., Miller R.R., et al. Mediastinal nodes in bronchogenic carcinoma: comparison between CT and mediastinoscopy. Radiology 167 (1988) 367-372
11. Dwamena B.A., Sonnad S.S., Angobaldo J.O., et al. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s-meta-analytic comparison of PET and CT. Radiology 213 (1999) 530-536
12. Adams S., Baum R.P., Stuckensen T., et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 25 (1998) 1255-1260
13. Marom E.M., McAdams H.P., Erasmus J.J., et al. Staging non-small cell lung cancer with whole-body PET. Radiology 212 (1999) 803-809
14. van Tinteren H., Hoekstra O.S., Smit E.F., et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 359 (2002) 1388-1393
15. Diederichs C.G., Staib L., Vogel J., et al. Values and limitations of 18F-fluorodeoxyglucosepositron-emission tomography with preoperative evaluation of patients with pancreatic masses. Pancreas 20 (2000) 109-116
16. Weber W.A., Avril N., and Schwaiger M. Relevance of positron emission tomography (PET) in oncology. Strahlenther Onkol 175 (1999) 356-373
17. Wahl R.L., Quint L.E., Cieslak R.D., et al. "Anatometabolic" tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity. J Nucl Med 34 (1993) 1190-1197
18. Townsend D.W. A combined PET/CT scanner: the choices. J Nucl Med 42 (2001) 533-534
19. Beyer T., Townsend D.W., and Blodgett T.M. Dual-modality PET/CT tomography for clinical oncology. Q J Nucl Med 46 (2002) 24-34
20. Cerfolio R.J., Ojha B., Bryant A.S., et al. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg 78 (2004) 1017-1023
21. Halpern B.S., Schiepers C., Weber W.A., et al. Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion. Chest 128 (2005) 2289-2297
22. Lardinois D., Weder W., Hany T.F., et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 19 (2003) 2500-2507
23. Aquino S.L., Asmuth J.C., Alpert N.M., et al. Improved radiologic staging of lung cancer with 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography and computed tomography registration. J Comput Assist Tomogr 27 (2003) 479-484
24. Buell U., Wieres F.J., Schneider W., et al. 18FDG-PET in 733 consecutive patients with or without side-by-side CT evaluation: analysis of 921 lesions. Nuklearmedizin 43 (2004) 210-216
25. Asamura H., Suzuki K., Kondo H., et al. Where is the boundary between N1 and N2 stations in lung cancer?. Ann Thorac Surg 70 (2000) 1839-1845
26. Antoch G., Stattaus J., Nemat A.T., et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 229 (2003) 526-533
27. Shim S.S., Lee K.S., Kim B.T., et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 236 (2005) 1011-1019
28. Reinartz P., Wieres F.J., Schneider W., et al. Side-by-side reading of PET and CT scans in oncology: which patients might profit from integrated PET/CT?. Eur J Nucl Med Mol Imaging 31 (2004) 1456-1461
29. Hutton B.F., and Braun M. Software for image registration: algorithms, accuracy, efficacy. Sem Nucl Med 33 (2003) 180-192
30. Vansteenkiste J.F., Stroobants S.G., Dupont P.J., et al. FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? The Leuven Lung Cancer Group. Eur J Nucl Med 25 (1998) 1495-1501
31. Keidar Z., Haim N., Guralnik L., et al. PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management. J Nucl Med 45 (2004) 1640-1646
32. Antoch G., Saoudi N., Kuehl H., et al. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 22 (2004) 4357-4368
33. Slomka P.J., Dey D., Przetak C., et al. Automated 3-dimensional registration of stand-alone (18)F-FDG whole-body PET with CT. J Nucl Med 44 (2003) 1156-1167
34. Beyer T., Antoch G., Muller S., et al. Acquisition protocol considerations for combined PET/CT imaging. J Nucl Med 45 Suppl 1 (2004) 25S-35S
35. Cohade C., Osman M., Marshall L.N., et al. PET-CT: accuracy of PET and CT spatial registration of lung lesions. Eur J Nucl Med Mol Imaging 30 (2003) 721-726
36. Antoch G., Freudenberg L.S., Egelhof T., et al. Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans. J Nucl Med 43 (2002) 1339-1342
37. Goerres G.W., Burger C., Schwitter M.R., et al. PET/CT of the abdomen: optimizing the patient breathing pattern. Eur Radiol 13 (2003) 734-739
38. Goerres G.W., Kamel E., Heidelberg T.N., et al. PET/CT image co-registration in the thorax: influence of respiration. Eur J Nucl Med Mol Imaging 29 (2002) 351-360
39. Beyer T., Antoch G., Blodgett T., et al. Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology. Eur J Nucl Med Mol Imaging 30 (2003) 588-596
40. Beyer T., Rosenbaum S., Veit P., et al. Respiration artifacts in whole-body (18)F-FDG PET/CT studies with combined PET/CT tomographs employing spiral CT technology with 1 to 16 detector rows. Eur J Nucl Med Mol Imaging 32 (2005) 1429-1439
41. Beyer T., Antoch G., Bockisch A., et al. Optimized intravenous contrast administration for diagnostic whole-body 18F-FDG PET/CT. J Nucl Med 46 (2005) 429-435